Triple-negative breast cancer (TNBC) is a clinically and molecularly distinct subtype of breast cancer defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression [1,2]. This evidence concerns the gene ERBB2 and breast carcinoma.